Prosecution Insights
Last updated: May 29, 2026

Emendobio Inc.

6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
3
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
1
Due this week
0
Due this month
0
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 7 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (83%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only4 (67%)
§102 only1 (17%)
§112 only1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DACE DENITO, ALEXANDRA GERALDINE 1 56.5% +36.3%
BRETZ, COREY LANE 1 0.0% +0.0%
JOHNSON, ALLISON MARIE 1 45.7% +50.0%
KONOPKA, CATHERINE ANNE 1 58.8% +63.7%
TRAN, CHRISTINA L 1 46.8% +51.2%
SHIN, DANA H 1 27.2% +27.6%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
16202955 DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS RHODOPSIN GENE SHIN, DANA H 6d
18257176 BIALLELIC KNOCKOUT OF TRAC BRETZ, COREY LANE 70d

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17433977 DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF STAT1 KONOPKA, CATHERINE ANNE 126d overdue
17420934 CRISPR COMPOSITIONS AND METHODS FOR PROMOTING GENE EDITING OF ADENOSINE DEAMINASE 2 (ADA2) TRAN, CHRISTINA L 112d overdue
17625290 DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF RPE65 JOHNSON, ALLISON MARIE 81d overdue
16202955 DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS RHODOPSIN GENE SHIN, DANA H 6d
18551817 COMPOSITIONS AND METHODS FOR TREATING HYPERCHOLESTEROLEMIA DACE DENITO, ALEXANDRA GERALDINE 68d

Top Art Units

Art UnitApps
1635 3
1636 1
1638 1
1637 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18551817 COMPOSITIONS AND METHODS FOR TREATING HYPERCHOLESTEROLEMIA DACE DENITO, ALEXANDRA GERALDINE 1636 §103 Non-Final OA 68d Pending Sep 21, 2023
18257176 BIALLELIC KNOCKOUT OF TRAC BRETZ, COREY LANE 1635 §102 Non-Final OA 70d Pending Jun 13, 2023
17625290 DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF RPE65 JOHNSON, ALLISON MARIE 1638 §103 Final Rejection 81d overdue Pending Jan 06, 2022
17433977 DIFFERENTIAL KNOCKOUT OF A HETEROZYGOUS ALLELE OF STAT1 KONOPKA, CATHERINE ANNE 1635 §103 Final Rejection 126d overdue Pending Aug 25, 2021
17420934 CRISPR COMPOSITIONS AND METHODS FOR PROMOTING GENE EDITING OF ADENOSINE DEAMINASE 2 (ADA2) TRAN, CHRISTINA L 1637 §103 Final Rejection 112d overdue Pending Jul 06, 2021
16202955 DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS RHODOPSIN GENE SHIN, DANA H 1635 §112 Non-Final OA 6d Pending Nov 28, 2018

Managing Emendobio Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month